Page last updated: 2024-09-03

lestaurtinib and Tauopathies

lestaurtinib has been researched along with Tauopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abagyan, R; Balboni, B; Cavalli, A; Demuro, S; Di Martino, RMC; Giabbai, B; Girotto, S; Ortega, JA; Russo, D; Sauvey, C; Shi, D; Storici, P; Tripathi, SK	1

Other Studies

1 other study(ies) available for lestaurtinib and Tauopathies

Article	Year
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders. European journal of medicinal chemistry, 2022, Feb-05, Volume: 229 Topics: Binding Sites; Drug Evaluation, Preclinical; Dyrk Kinases; Glycogen Synthase Kinase 3 beta; Humans; Microtubules; Models, Molecular; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Structure-Activity Relationship; tau Proteins; Tauopathies	2022

Article

Year

ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.

European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

Topics: Binding Sites; Drug Evaluation, Preclinical; Dyrk Kinases; Glycogen Synthase Kinase 3 beta; Humans; Microtubules; Models, Molecular; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Structure-Activity Relationship; tau Proteins; Tauopathies

2022